ARRive Growth Partners Launches Embedded Fractional Commercial Leadership for Healthtech

Make ARR predictable. Protect runway. Run one accountable commercialization system that compresses enterprise timelines to signature.

NASHVILLE, Tenn., Sept. 24, 2025 /PRNewswire/ -- ARRive Growth Partners has launched an embedded fractional commercial leadership model purpose-built for healthtech. The firm unites sales and marketing under one accountable plan to compress enterprise timelines and deliver predictable, defensible ARR - without premature full-time headcount. ARRive embeds as the single accountable owner across pipeline, campaigns, and deals so results start now. Founders can also start with one lane - sales-only or marketing-only - and run the same engine: one plan, one cadence, one forecast.

In healthtech, the breakdown is commercialization - misaligned sales/marketing, conference churn, founder-led selling, and premature hiring before true fit.

"Your process determines your ARR. Headcount is expensive; process is compounding. ARRive installs a commercialization system - so whether you start with sales or marketing, you run as one. Founders fear 'fractional' means fragmented; ours is unified: one owner across pipeline, campaigns, and deals. That's how you compress time-to-signature and grow ARR predictably," said Scott Heatherly, Founder & CEO of ARRive Growth Partners.

What ARRive installs: the Healthtech ARR Flywheel™

• Predictable pipeline & forecast discipline: deal-desk ownership, weekly cadence with exits, 48-hour next steps - no drift, defensible forecasts.
• Consensus that moves: ICP precision, persona pathways, targeted change-maker mapping inside accounts - sequenced reviews, executive momentum.
• Message-to-terms continuity: shared ICP and narrative across campaigns, meetings, and executive briefs, persona evidence with ROI/payback, before–after operational deltas - one motion, stronger consensus.
• Faster signatures: live deal acceleration, budget pathing, procurement/BAA/MSA and InfoSec readiness - controlled timelines, higher win rates.

Start where you are; run as one

Many teams start with sales-only or marketing-only; ARRive aligns both to one ICP, story, stages, and forecast seamlessly.

Who ARRive serves

ARRive partners with early to late-stage healthtech startups and investors seeking enterprise-grade commercialization without premature hiring. Typical engagements begin with a 90-day sprint focused on late-stage deal momentum, proof packaging, and a board-ready operating rhythm, then scale as traction compounds.

About ARRive Growth Partners

ARRive Growth Partners is an embedded fractional commercial partner for healthtech companies selling into health systems. The firm unites sales and marketing into one motion that surfaces real decision points, raises win rates, and builds forecastable ARR - without premature headcount. Learn more at www.arrivegrowthpartners.com.

Media Contact
ARRive Growth Partners - [email protected]

SOURCE ARRive Growth Partners